Search Results

SC-4013: Developing Evidence-Based Criteria for Initiating Treatment for Neurofibromatosis Type 1 Associated Optic Pathway Glioma-STUDY00000461

To learn more about this study, please email the study team member listed below.

Ceribell Headcap Safety and Performance Evaluation-STUDY00004160

The primary aim of this study is to evaluate the safety and performance of the newly developed Ceribell Headcap used in conjunction with the...

Amy Lee, MD

Amy Lee, MD, Division Chief, Neurosurgery; Fellowship Director; Pediatric Neurosurgery; Associate Residency Program Director, Pediatric Neurosurgery;...

Andrew Daniel Linkugel, MD

Andrew Daniel Linkugel, MD specializing in Craniofacial Center

Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial (ADJUST)-STUDY00002134

Multicenter, block-randomized, double-masked, placebo-controlled trial to compare the safety and efficacy of stopping adalimumab treatment versus...

ACNS2321: A Phase II Trial Evaluating Chemotherapy followed by Response-Based Reduced Radiation Therapy for Patients with Central Nervous System Germinomas-STUDY00005171

Germinomas account for more than two thirds of intracranial germ cell tumors (GCT).1, 2 The current treatment regimens lead to excellent outcomes,...

Phase 1b/2, randomized, double-blind, placebo-controlled, multi-center study of STMC-103H in neonates and infants at high-risk for developing allergic disease-STUDY00003212

Primary indication is to see is STMC-103H, prevents allergic disease in at-risk neonates. The primary objective of this study is to assess the...

Meet the Team - MacDuffie Lab - Seattle Children's

Meet the Team Kate MacDuffie, MA, PhD Dr. MacDuffie is an investigator in the Treuman Katz Center for Pediatric Bioethics and Palliative Care and...

Buzz (Has Degree) Smith, DDS

Buzz (Has Degree) Smith, DDS

Chuan Zhou, PhD

Chuan Zhou, PhD, Research Associate Professor